US Patent Issued to NEUROCHASE INNOVATIONS on Oct. 28 for "Biologically inert fluid for use in the treatment of a CNS disorder" (British Inventor)

ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,453,784, issued on Oct. 28, was assigned to NEUROCHASE INNOVATIONS LTD (Cardiff, Great Britain).

"Biologically inert fluid for use in the treatment of a CNS disorder" was invented by Steven S. Gill (Bristol, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a biologically inert fluid for use in the treatment of a CNS disorder, wherein the biologically inert fluid is to be infused into the brain via convection enhanced delivery (CED) in combination with a therapeutic agent."

The patent was filed on Aug. 5, 2019, under Application No. 17/264,973.

*For further information, including images, charts and tables, ple...